Decreased expression of the insulin-like growth factor-I-binding protein-1 (IGFBP-1) phosphoisoform in pre-eclamptic Whartons jelly and its role in the regulation of collagen biosynthesis

Insulinlike growth factor-I (IGF-I) is known as an important stimulator of collagen and glycosaminoglycans (GAGs) biosynthesis in tissues. IGF-I activity is under control of IGF-I binding proteins (IGFBPs) with different IGF-I binding affinity. IGFBP-1 is known as an inhibitor of IGF-dependent functions. Some IGFBPs (e.g., IGFBP-1) may undergo phosphorylation that dramatically increases IGFBP affinity for IGF. Whartons jelly represents a reservoir of IGF-I and its binding proteins (BPs). Preeclampsia, the most common, pregnancy-associated pathological syndrome, contributes to a significant decrease in IGF-I and IGFBP-1 content in Whartons jelly, although it does not affect collagen content in this tissue. In the present study we show that control Whartons jelly contains phosphorylated forms of IGFBP-1 that are dramatically dephosphorylated during pre-eclampsia. A dramatic decrease in IGF-I binding to immunoprecipitated IGFBP-1 from pre-eclamptic Whartons jelly compared to the control was observed. Western immunoblot analysis with anti-phosphothreonine antibodies for immunoprecipitated IGFBP-1 from control and pre-eclamptic Whartons jelly revealed that both tissues contain phosphorylated forms of IGFBP-1. However, a distinct decrease in the expression of phosphorylated IGFBP-1 from pre-eclamptic Whartons jelly was observed. The functional significance of the phenomenon was found in cultured fibroblasts treated with IGFBP isolated from Whartons jelly extracts. A significant decrease in collagen biosynthesis was found in the cells treated with IGFBP of control Whartons jelly, while in the presence of IGFBP from pre-eclamptic Whartons jelly, the rate of collagen biosynthesis was similar to that in the control cells. The result was corroborated by data showing increase in expression of IGF-I receptor and phosphorylated MAP kinases (ERK1 and ERK2) in fibroblasts cultured in the presence of IGFBP from pre-eclamptic Whartons jelly, compared to control. The data suggest that the decrease in phosphorylated IGFBP-1 in pre-eclamptic Whartons jelly may decrease IGF-I-binding affinity for IGF and increase the bioavailability of IGF-I for receptor interaction. This mechanism may facilitate IGF-I-dependent stimulation of fibroblasts to produce extracellular matrix (ECM) components even at a low IGF-I tissue level. Therefore, IGFBP-1 phosphoisoforms in Whartons jelly may play an important role in the regulation of IGF-I-dependent functions during pre-eclampsia.